Roth, Lauren K, Associate Commissioner for Policy, Food and Drug Administration. Docket No. FDA-2023-P-0038: Determination That CUBICIN (Daptomycin) Powder for Injection, 250 Milligrams/Vial and 500 Milligrams/Vial, and CUBICIN RF (Daptomycin) Powder for Injection, 500 Milligrams/Vial, Were Not Withdrawn from Sale for Reasons of Safety or Effectiveness. 88 Federal Register 52182 (Aug 2, 2023). www.federalregister.gov/documents/2023/08/07/2023-16775/determination-that-cubicin-daptomycin-powder-for-injection-250-milligramsvial-and-500-milligramsvial